Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Important Safety Information Who should not use tirzepatide: Type 1 diabetes patients (tirzepatide is not approved for type 1 diabetes) History of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Identifying and limiting personal trigger foods reduces ongoing acid exposure even as tissue healing progresses
It addresses the biological mechanisms that drive overeating and fat storage at their source, offering men a tool that actually aligns with how male metabolism functions
Free dose calculator, full reconstitution chart, 5 errors to avoid
Weight loss trajectory was still accelerating Phase 1 (oral): 10.4-13.1% weight loss at 12 weeks depending on dosing regimen vs 1.2% placebo Phase 2 (T2D): SC amycretin showed up to 14.5% weight loss and HbA1c reductions up to 1.8% at 36 weeks
US$ 24.80
US$ 28.45
US$ 21.16
US$ 23.07
US$ 24.48
US$ 29.26
US$ 21.50